- Home
- ARAY vs AMRN Comparison
ARAY vs AMRN Comparison
Compare ARAY & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- AMRN
- Stock Information
- Founded
- ARAY 1990
- AMRN 1989
- Country
- ARAY United States
- AMRN Ireland
- Employees
- ARAY N/A
- AMRN N/A
- Industry
- ARAY Medical/Dental Instruments
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ARAY Health Care
- AMRN Health Care
- Exchange
- ARAY Nasdaq
- AMRN Nasdaq
- Market Cap
- ARAY 229.3M
- AMRN 189.2M
- IPO Year
- ARAY 2007
- AMRN 1993
- Fundamental
- Price
- ARAY $2.11
- AMRN $0.59
- Analyst Decision
- ARAY Strong Buy
- AMRN Buy
- Analyst Count
- ARAY 1
- AMRN 1
- Target Price
- ARAY $9.00
- AMRN N/A
- AVG Volume (30 Days)
- ARAY 883.1K
- AMRN 991.3K
- Earning Date
- ARAY 02-05-2025
- AMRN 03-12-2025
- Dividend Yield
- ARAY N/A
- AMRN N/A
- EPS Growth
- ARAY N/A
- AMRN N/A
- EPS
- ARAY N/A
- AMRN N/A
- Revenue
- ARAY $453,140,000.00
- AMRN $241,021,000.00
- Revenue This Year
- ARAY $6.97
- AMRN N/A
- Revenue Next Year
- ARAY $5.02
- AMRN N/A
- P/E Ratio
- ARAY N/A
- AMRN N/A
- Revenue Growth
- ARAY 1.26
- AMRN N/A
- 52 Week Low
- ARAY $1.40
- AMRN $0.43
- 52 Week High
- ARAY $2.95
- AMRN $1.36
- Technical
- Relative Strength Index (RSI)
- ARAY 43.05
- AMRN 55.53
- Support Level
- ARAY $2.15
- AMRN $0.56
- Resistance Level
- ARAY $2.32
- AMRN $0.59
- Average True Range (ATR)
- ARAY 0.16
- AMRN 0.04
- MACD
- ARAY -0.04
- AMRN 0.00
- Stochastic Oscillator
- ARAY 4.55
- AMRN 71.91
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.